AnalyzeDirect Bantick RA, Montgomery AJ, Bench CJ, Choudhry T, Malek N, McKenna PJ, Quested DJ, Deakin JF, Grasby PM. A positron emission tomography study of the 5-HT1A receptor in schizophrenia and during clozapine treatment. J Psychopharmacol. September 2004;18(3):346-354.
Publication Date
September 2004
How Analyze was Used
“Hand-placed regions were defined on these MRI images using Analy[z]e version 4.0 software.”
Keywords
Adult
Antipsychotic Agents/pharmacology/therapeutic use
Brain/metabolism/radionuclide imaging
Clozapine/pharmacology/therapeutic use
Humans
Male
Middle Aged
Piperazines/pharmacology
Positron-Emission Tomography (PET)
Pyridines/pharmacology
Receptor, Serotonin, 5-HT1A/metabolism
Schizophrenia/drug therapy/metabolism/radionuclide imaging
Serotonin Antagonists/pharmacology
Time Factors
Author Affiliation(s)
Cyclotron Unit, CSC, The Hammersmith Hospital, Imperial College London, London, UK.
ID# 2297
Tags: Adult, Antipsychotic Agents/pharmacology/therapeutic use, Brain/metabolism/radionuclide imaging Clozapine/pharmacology/therapeutic use, Humans, Male, Middle Aged, Piperazines/pharmacology, Positron Emission Tomography (PET), Pyridines/pharmacology, Schizophrenia/drug therapy/metabolism/radionuclide imaging, Serotonin Antagonists/pharmacology, Serotonin Receptor_5-HT1A/metabolism, Time Factors